SHIVALIK RASAYAN LIMITED
SHIVALIK · General/Diversified · NSE
₹255
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for SHIVALIK yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
6/9
Economic Moat
None
Confidence
13%
ROE
3.1%
Debt/Equity
0.20
WACC
11.1%
Market Cap
₹401.48 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
7.6%
Return on capital employed
EV / EBITDA
10.1×
Enterprise multiple
Debt / EBITDA
2.5×
Leverage vs earnings
Interest Coverage
3.5×
EBIT covers interest
Current Ratio
1.77×
Short-term liquidity
Asset Turnover
0.46×
Revenue per ₹ of assets
Revenue CAGR (3Y)
16.3%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
SHIVALIK · last 4 annual periods
ROE
3.1%
ROCE
7.6%
Operating Margin
—
Debt / Equity
0.20×
PE
50.7×
EV / EBITDA
22.8×
Historical Financials
SHIVALIK · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹207 Cr | ₹234 Cr | ₹272 Cr | ₹310 Cr | +14.4% |
| EBITDA | ₹50.5 Cr | ₹47.6 Cr | ₹43.3 Cr | ₹48.5 Cr | -1.3% |
| EBIT | ₹39.5 Cr | ₹36.0 Cr | ₹30.8 Cr | — | -7.9% |
| PAT | ₹25.6 Cr | ₹20.7 Cr | ₹12.7 Cr | ₹16.7 Cr | -13.3% |
| EPS (diluted) | ₹18.12 | ₹15.02 | ₹10.75 | — | -16.0% |
| CFO | ₹11.1 Cr | ₹-18.9 Cr | ₹-8.1 Cr | ₹-9.2 Cr | — |
| CapEx | ₹-25.0 Cr | ₹-63.2 Cr | ₹-67.7 Cr | ₹-22.6 Cr | — |
| FCF | ₹-13.8 Cr | ₹-82.2 Cr | ₹-75.7 Cr | ₹-31.8 Cr | — |
| Total Assets | ₹488 Cr | ₹578 Cr | ₹692 Cr | ₹734 Cr | +14.6% |
| Total Debt | ₹41.1 Cr | ₹65.5 Cr | ₹86.0 Cr | ₹105 Cr | +36.6% |
| Shareholders' Equity | ₹287 Cr | ₹310 Cr | ₹390 Cr | ₹415 Cr | +13.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SHIVALIK vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
IGCL INDOGULF CROPSCIENCES LTD | +70.4% | 40 | Data Limited | 10.9% | — |
ARIES ARIES | — | — | Pending | 11.7% | — |
RAMAPHO RAMA PHOSPHATES LIMITED | +181.2% | 40 | Data Limited | 13.3% | — |
KHAICHEM KHAITAN CHEM & FERT LTD | +192.9% | 40 | Data Limited | 22.2% | — |
NATHBIOGEN NATHBIOGEN | — | — | Pending | 6.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
4 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹2.00/sh
Last payout
2025-09-19
₹0.50
Peak payout
₹0.50
Trailing yield
0.20%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of SHIVALIK →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SHIVALIK →
Compare
Head-to-head with peers
Compare SHIVALIK side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SHIVALIKNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.